Department of Medicine, Division of Hematology, Stanford University, Stanford, California, United States of America
Department of Statistics, Stanford University, Stanford, California, United States of America
Department of Dermatology, J. Gutenberg-University, Mainz, Germany
ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
Norris Cancer Center, University of Southern California, Los Angeles, California, United States of America
Post a new comment on this article
The Quest for a Vaccine That Yields Tumor-Killing T cells
Using Modified Antigenic Sequences to Develop Cancer Vaccines: Are We Losing the Focus?
We want your feedback. Do these subject areas make sense for this article? If not, click the flag
next to the incorrect subject area and we will review it. Thanks for your help!
Response to Speiser et al.Posted by plosmedicine
Tumor cell recognition efficiency by T cellsPosted by plosmedicine
Ambra 2.10.6 Managed Colocation provided by Internet Systems Consortium.
Send us feedback